XTL BIOPHARMACEUTICALS LTD. Reduction Of Issued Capital
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Reduction Of Issued Capital of $2.89 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:ReductionOfIssuedCapital · last filed 2025-04-30
| Period end | Reduction Of Issued Capital 12 month |
|---|---|
| 2024-12-31 | $2.89M 20-F · filed 2025-04-30 |
| 2019-12-31 | $165.00K 20-F · filed 2020-03-12 |
| 2018-12-31 | $165.00K 20-F · filed 2019-03-11 |
| 2017-12-31 | $165.00K 20-F · filed 2018-03-15 |